Publication | Closed Access

Five-year Outcome of Stereotactic Hypofractionated Accurate Radiotherapy of the Prostate (SHARP) for Patients with Low-risk Prostate Cancer

UrologySurgical OncologyRadiation TherapyLow-risk Prostate CancerFive-year OutcomeProstatic DiseaseMedicineRadiation OncologyTreatment VerificationRadiologyHealth Sciences